To elucidate the molecular mechanism by which cyclobrachycoumarin induces cell cycle arrest, we analyzed the expression levels of key cell cycle-related proteins, including cyclin D1 and CDK1 in CRC cells, following cyclobrachycoumarin treatment [31]. This evidence concerns the gene CDK1 and colorectal carcinoma.